Sign in
8-K

Current Report

Damora Therapeutics, Inc. Filed Acc 0001193125-20-285653

Bylaws or fiscal year change

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing